YANKCOM Partnership’s Eli Lilly LLY Stock Holding History

YANKCOM Partnership’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.31M	Sell	1,997 -34	-2%	-$40.1K	0.8%	25
2026 Q2	$2.44M	Buy	2,031 +693	+52%	+$708K	0.87%	23
2026 Q1	$1.23M	Sell	1,338 -24	-2%	-$24.3K	0.51%	48
2025 Q4	$1.46M	Buy	1,362 +434	+47%	+$415K	0.62%	39
2025 Q3	$708K	Buy	928 +34	+4%	+$25.3K	0.32%	78
2025 Q2	$697K	Buy	894 +5	+0.6%	+$3.88K	0.34%	76
2025 Q1	$734K	Sell	889 -36	-4%	-$30K	0.4%	69
2024 Q4	$714K	Buy	+925	New	+$766K	0.38%	75

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

YANKCOM Partnership's LLY Position: Q3 2026 in Review

YANKCOM Partnership reduced its Eli Lilly (LLY) stake by 1.7% in Q3 2026, selling an estimated $40.1K and leaving 1,997 shares worth $2.31M. The position accounts for 0.8% of the portfolio, ranked #25.

YANKCOM Partnership first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.44M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

YANKCOM Partnership held 1,997 shares of Eli Lilly worth $2.31M as of Q3 2026.
YANKCOM Partnership sold 34 Eli Lilly shares in Q3 2026, an estimated $40.1K.
Eli Lilly made up 0.8% of YANKCOM Partnership's portfolio in Q3 2026, its #25 holding.
YANKCOM Partnership first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
YANKCOM Partnership's Eli Lilly position peaked at $2.44M in Q2 2026.
3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.